• Home

Home > Medical Reference > Patient Education

• Highlights
• Introduction
• Causes
• Symptoms
• Prognosis
• Risk Factors
• Diagnosis
• Treatment
• Medications
• Surgery
• Prevention
• Resources
• References

Pneumonia

Description

An in-depth report on the causes, diagnosis, treatment, and prevention of pneumonia.

References

Little P, Rumsby K, Kelly J, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA . 2005;293(24):3029-3035.

Rainer, TH. Severe Acute Respiratory Syndrome: Clinical Features, Diagnosis, and Management. Curr Opin Pulm Med. 10(3):159-165, 2004.

Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid–suppressive drugs. JAMA . 2004;292:1955-1960.

Yang ZY, Kong WP, Huang Y, et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature . 2004;428(6982):561-564.

Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C; Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis . 2003;37(11):1405-1433.

Apisarnthanarak A, Mundy LM. Etiology of Community-Acquired Pneumonia. Clin Chest Med . 2005;26:47-55.

Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for pneumocystis from humans. Emerg Infect Dis [serial online] 2002;8.

Cohen J, Powderly WG, Berkley SF, et al. eds. Infectious Diseases . 2nd ed. New York, NY: Mosby; 2004:703-706.

Whitty JE, Dombrowski MP. Respiratory Disease in Pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL, et al. eds. Obstetrics: Normal and Problem Pregnancies . 4th ed. New York, NY:  Churchill Livingstone; 2002:1033-36.

US Food and Drug Administration. Product Safety Alerts: Tequin (gatifloxacin). Created: February 15, 2006. Rockville, MD; February 22, 2006.

Centers for Disease Control and Prevention. CDC Health Alert: CDC Recommends against the Use of Amantadine and Rimantadine for the Treatment or Prophylaxis of Influenza in the United States during the 2005-06 Influenza Season. Posted January 14, 2006.

• Review Date: 3/28/2006
• Reviewed By: Harvey Simon, MD, Editor-in-Chief, Associate Professor of Medicine, Harvard Medical School; Physician, Massachusetts General Hospital

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.